Dana dhuwit perusahaan: unitybiotechnology.com (UBX)

Unity Bio (UBX) - logo korporat

Unity Biotechnology (UBX) pricing power potential depends on FDA approval of its joint and vision drugs. The cash volume trend clearly demonstrates the company's liquidity, where 0.00 shows the current value of the metric. Unity Biotechnology (UBX) develops senolytics to combat aging, targeting the massive regenerative medicine market. Meanwhile, the laboratories are implementing zero-waste synthesis methods to reduce water consumption.

Cadangan dhuwit perusahaan: Unity Biotechnology Inc. (UBX) kanggo 04.07.2022 - 19.07.2025

Ringkesan rincian data analitis Unity Bio (UBX)

- nilai saham lan prakiraan konsensus rega:
- indikator kapitalisasi bursa perusahaan:
Analisis komprehensif perusahaan:Unity Biotechnology
Sampel barang Unity Biotechnology Inc.

Unity Biotechnology is tapping into the colossal regenerative medicine market by developing therapies for age-related pathologies. This cash balance figure demonstrates the company's ability to fund costly senolytic research and development without external support. The metric captures the actual liquidity remaining in accounts, excluding illiquid assets. Comparing these funds with the burn rate reveals the risk of a cash shortfall. A stable capital reserve confirms the viability of the issuer's business model.

Perusahaan pesaing

Volume dana dhuwit perusahaan TEM|QGEN - Cadangan dhuwit perusahaan|ionispharma.com - Dhuwit awis perusahaan|Sisa dhuwit perusahaan RGEN|Avidity Corp - Volume dana dhuwit perusahaan|CRISPR Therapeutics Corp - Gunggung dana dhuwit perusahaan|GeneDx Holdings (WGS) - Dana dhuwit perusahaan|Ultragenyx Pharmaceutical (RARE) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan BEAM|Sarepta (SRPT) - Aset likuid perusahaan|Dana dhuwit perusahaan Twist Bioscience Corp (TWST)|10x - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan NTLA (intelliatx.com)|Gunggung dana dhuwit perusahaan STOK (stoketherapeutics.com)|BioLife Solutions Inc - Volume dana dhuwit perusahaan|WVE (Wave Life Sciences Ltd) - Dhuwit awis lan setara dhuwit awis perusahaan|Maze Therapeutics Corp (MAZE) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan SION|PRME (Prime Medicine Inc) - Volume dana dhuwit perusahaan|Taysha Gene Therapies (TSHA) - Aset likuid perusahaan|Dhuwit awis perusahaan QURE (uniqure.com)|Gunggung dana dhuwit perusahaan MGTX|Volume dana dhuwit perusahaan RGNX (regenxbio.com)|SLDB: Dhuwit awis lan setara dhuwit awis perusahaan|ocugen.com - Volume dana dhuwit perusahaan|PACB - Volume dana dhuwit perusahaan|BNTC: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan DSGN|Dana dhuwit perusahaan Rocket Pharmaceuticals|Dhuwit awis perusahaan 4DMT (FDMT)|Volume dana dhuwit perusahaan LXEO|Aset likuid perusahaan Korro Bio Inc.|Volume dana dhuwit perusahaan EDIT (Editas Medicine Inc)|SLN: Dhuwit awis lan setara dhuwit awis perusahaan|PRQR - Dana dhuwit perusahaan|Aset likuid perusahaan codexis.com CDXS|SGMO: Volume dana dhuwit perusahaan|Nautilus Biotechnology (NAUT) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Metagenomi, Inc|precisionbiosciences.com (DTIL) - Aset likuid perusahaan|Dana dhuwit perusahaan Generation Bio Co. (GBIO)|Aset likuid perusahaan Boundless Bio, Inc.|Dana dhuwit perusahaan Exicure, Inc. XCUR|IMNN: Dhuwit awis lan setara dhuwit awis perusahaan|PHIO - Dana dhuwit perusahaan|Aset likuid perusahaan Mustang Bio MBIO|RNAZ: Volume dana dhuwit perusahaan|Posisi dhuwit perusahaan Bionano Genomics Inc. BNGO|APDN (Applied DNA Corp) - Volume dana dhuwit perusahaan|bluebirdbio.com (BLUE) - Aset likuid perusahaan|Volume dana dhuwit perusahaan IPA|Volume dana dhuwit perusahaan Omega (OMGA)|Dana dhuwit perusahaan Singular Genomics Systems Inc OMIC|Volume dana dhuwit perusahaan Regulus RGLS|syros.com - Volume dana dhuwit perusahaan|TBIO: Dana dhuwit perusahaan|TCON: Volume dana dhuwit perusahaan